AVITA Medical, Inc. (RCEL) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$2,396
Total Return
-76.04%
CAGR
-24.86%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.55% |
| Median | -3.22% |
| Best | +58.48% |
| Worst | -48.36% |
| % of Windows Positive | 43.9% |
1-Year (252 Trading Days)
| Average | +0.03% |
| Median | -39.49% |
| Best | +282.17% |
| Worst | -77.87% |
| % of Windows Positive | 34.7% |
3-Year (756 Trading Days)
| Average | -27.08% |
| Median | -33.29% |
| Best | +50.98% |
| Worst | -72.58% |
| % of Windows Positive | 21.4% |
Risk Metrics
| Maximum Drawdown | -85.15% |
| Average Drawdown | -52.44% |
| Drawdown Duration | 1209 Trading Days (Unrecovered) |
| Sortino Ratio | -0.01 |
| Calmar Ratio | -0.29 |
| CVaR (5%) | -9.68% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +38.26% (+190.39% ann.) | +$3826.09 | $0.00 | $0.00 | $0.00 |
| 2025 | -73.05% | $7304.69 | $0.00 | $0.00 | $0.00 |
| 2024 | -6.71% | $670.55 | $0.00 | $0.00 | $0.00 |
| 2023 | +107.88% | +$10787.88 | $0.00 | $0.00 | $0.00 |
| 2022 | -44.91% | $4490.82 | $0.00 | $0.00 | $0.00 |
| 2021 | -35.52% | $3552.21 | $0.00 | $0.00 | $0.00 |
| 2020 | -59.16% | $5916.48 | $0.00 | $0.00 | $0.00 |
| 2019 | +712.50% | +$71250.00 | $0.00 | $0.00 | $0.00 |
| 2018 | +4.67% | +$467.29 | $0.00 | $0.00 | $0.00 |
| 2017 | -41.85% | $4184.78 | $0.00 | $0.00 | $0.00 |
| 2016 | +24.32% | +$2432.43 | $0.00 | $0.00 | $0.00 |
| 2015 | +19.35% | +$1935.48 | $0.00 | $0.00 | $0.00 |
| 2014 | -51.56% | $5156.25 | $0.00 | $0.00 | $0.00 |
| 2013 | +2.40% | +$240.00 | $0.00 | $0.00 | $0.00 |
| 2012 partial | -50.00% (-66.58% ann.) | $5000.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy-led rebound / euro-sovereign-crisis overlay partial | May 14, 2012 – July 25, 2012 | -20.20% | -68.17% | $2020.00 | $0.00 | $0.00 | $0.00 |
| Secular stagnation / QE / low inflation / duration bull | July 26, 2012 – February 19, 2020 | +202.47% | +15.75% | +$20246.58 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -58.05% | -100.00% | $5804.88 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -7.71% | -12.11% | $770.88 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -40.41% | -38.81% | $4041.18 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -60.54% | -62.74% | $6053.78 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +67.65% | +32.15% | +$6764.71 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | -54.22% | -38.86% | $5422.26 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.